nach oben

Somnologie

Erschienen in:

12.02.2024 | Parkinson-Krankheit | CME

Schlafstörungen bei Parkinson-Krankheit

verfasst von: Kirsi Lange, Jan Simon Gerdes, Berthold Voges

Erschienen in: Somnologie | Ausgabe 1/2024

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Bei Patienten mit Parkinson-Krankheit (PK) wird der Schlaf einerseits durch motorische und nichtmotorische Symptome beeinflusst, andererseits werden durch Neurodegeneration die Schlaf-Wach-Rhythmus regulierenden Netzwerke gestört. Zum Spektrum möglicher somnologischer Erkrankungen bei PK zählen daher alle Kategorien der International Classification of Sleep Disorders 3 (ICSD‑3): Parasomnien, v. a. REM-Schlaf-Verhaltensstörung („REM sleep behavior disorder“, RBD), Insomnie, exzessive Tagesschläfrigkeit, zirkadiane Schlaf-Wach-Rhythmusstörungen, schlafbezogene Bewegungs- (v. a. Restless-Legs-Syndrom, RLS, und „periodic limb movement disorder“, PLMD) und schlafbezogene Atmungsstörungen (SBAS). Die Erkrankungen bestehen häufig gleichzeitig und nehmen mit Krankheitsprogress zu. Außerdem sind Erkennen und Vermeiden unerwünschter Arzneimittelwirkungen wichtig, um individualisierte Therapie zu ermöglichen und damit die Lebensqualität der Betroffenen und der Betreuungspersonen zu verbessern.

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J et al (2015) MDS clinical diagnostic criteria for parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/mds.26424CrossRefPubMed

Heinzel S, Berg D, Binder S, Ebersbach G, Hickstein L, Herbst H, Lorrain M et al (2018) Do we need to rethink the epidemiology and healthcare utilization of parkinson’s disease in Germany? Front Neurol 29(9):500. https://doi.org/10.3389/fneur.2018.00500CrossRef

Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of parkinson disease. Nat Rev Neurosci 18(7):435–450. https://doi.org/10.1038/nrn.2017.62CrossRefPubMed

Schütz L, Sixel-Döring F, Hermann W (2022) Management of sleep disturbances in parkinson’s disease. J Parkinsons Dis 12(7):2029–2058. https://doi.org/10.3233/JPD-212749CrossRefPubMedPubMedCentral

Scott-Massey A, Boag MK, Magnier A, Bispo DPCF, Khoo TK, Pountney DL (2022) Glymphatic system dysfunction and sleep disturbance may contribute to the pathogenesis and progression of parkinson’s disease. Int J Mol Sci 23(21):12928. https://doi.org/10.3390/ijms232112928CrossRefPubMedPubMedCentral

Dhawan V, Healy DG, Pal S, Chaudhuri KR (2006) Sleep-related problems of parkinson’s disease. Age Ageing 35(3):220–228. https://doi.org/10.1093/ageing/afj087CrossRefPubMed

Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of parkinson’s disease. Clin Neuropharmacol 11(6):512–519. https://doi.org/10.1097/00002826-198812000-00004CrossRefPubMed

Stefansdottir S, Gjerstad MD, Tysnes OB, Larsen JP (2012) Subjective sleep problems in patients with early parkinson’s disease. Eur J Neurol 19(12):1575–1581. https://doi.org/10.1111/j.1468-1331.2012.03791.xCrossRefPubMed

Perez E, Perrin PB, Lageman SK, Villaseñor T, Dzierzewski JM (2022) Sleep, caregiver burden, and life satisfaction in parkinson’s disease caregivers: a multinational investigation. Disabil Rehabil 44(10):1939–1945. https://doi.org/10.1080/09638288.2020.1814878CrossRefPubMed

10.

Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in parkinson’s disease. Parkinsonism Relat Disord 8(3):193–197. https://doi.org/10.1016/s1353-8020(01)00015-3CrossRefPubMed

11.

Höglinger G, Trenkwalder C et al (2023) Parkinson-Krankheit, S2k-Leitlinie, in: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. www.dgn.org/leitlinien. Zugegriffen: 11. Nov. 2023

12.

Muntean ML, Benes H, Sixel-Döring F, Chaudhuri KR, Suzuki K, Hirata K, Zimmermann J, Trenkwalder C (2016) Clinically relevant cut-off values for the parkinson’s disease sleep scale‑2 (PDSS-2): a validation study. Sleep Med 24:87–92. https://doi.org/10.1016/j.sleep.2016.06.026CrossRefPubMed

13.

Bhidayasiri R, Sringean J, Trenkwalder C (2020) Mastering nocturnal jigsaws in parkinson’s disease: a dusk-to-dawn review of night-time symptoms. J Neural Transm 127(5):763–777. https://doi.org/10.1007/s00702-020-02170-6CrossRefPubMed

14.

Bhidayasiri R, Trenkwalder C (2018) Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in parkinson’s disease. Parkinsonism Relat Disord 50:10–18. https://doi.org/10.1016/j.parkreldis.2018.01.008CrossRefPubMed

15.

Uchino K, Shiraishi M, Tanaka K, Akamatsu M, Hasegawa Y (2017) Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with parkinson’s disease. PLoS ONE 12(11):e187616. https://doi.org/10.1371/journal.pone.0187616CrossRefPubMedPubMedCentral

16.

Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H, The Neurourology Promotion Committee in The International Continence Society The Parkinson (2016) A guideline for the management of bladder dysfunction in parkinson’s disease and other gait disorders. Neurourol Urodyn 35(5):551–563. https://doi.org/10.1002/nau.22764CrossRefPubMed

17.

Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel-Döring F, Frauscher B, Hülsmann J, Martinez-Martin P, Chaudhuri KR (2011) Parkinson’s disease sleep scale—validation of the revised version PDSS‑2. Mov Disord 26(4):644–652. https://doi.org/10.1002/mds.23476CrossRefPubMed

18.

Heidbreder A, Trenkwalder C et al (2022) Restless Legs Syndrom, S2k-Leitlinie, Deutsche Gesellschaft für Neurologie und Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM) (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. www.dgn.org/leitlinien. Zugegriffen: 15. Okt. 2023

19.

Teman PT, Tippmann-Peikert M, Silber MH, Slocumb NL, Auger RR (2009) Idiopathic rapid-eye-movement sleep disorder: Associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med 10(1):60–65. https://doi.org/10.1016/j.sleep.2007.11.019CrossRefPubMed

20.

Allada R, Bass J (2021) Circadian Mechanisms in Medicine. N Eng J Med 384(6):550–561. https://doi.org/10.1056/NEJMra1802337CrossRef

21.

Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC (2014) Circadian melatonin rhythm and excessive daytime sleepiness in parkinson disease. JAMA Neurol 71(4):463–469. https://doi.org/10.1001/jamaneurol.2013.6239CrossRefPubMedPubMedCentral

22.

Suzuki K (2021) Current update on clinically relevant sleep issues in parkinson’s disease: a narrative review. J Parkinsons Dis 11(3):971–992. https://doi.org/10.3233/JPD-202425CrossRefPubMedPubMedCentral

23.

De Cock VC, Vidailhet M, Arnulf I (2008) Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4(5):254–266. https://doi.org/10.1038/ncpneuro0775CrossRefPubMed

24.

Tandberg E, Larsen JP, Karlsen K (1999) Excessive daytime sleepiness and sleep benefit in parkinson’s disease: a community-based study. Mov Disord 14(6):922–927. https://doi.org/10.1002/1531-8257(199911)14:6 (〈 922::AID-MDS1003 〉 3.0.CO;2-7)CrossRefPubMed

25.

Zuzuárregui JRP, During EH (2020) Sleep issues in parkinson’s disease and their management. Neurotherapeutics 17(4):1480–1494. https://doi.org/10.1007/s13311-020-00938-yCrossRefPubMedPubMedCentral

26.

Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M (2019) Daytime sleepiness may be an independent symptom unrelated to sleep quality in parkinson’s disease. J Neurol 266(3):636–341. https://doi.org/10.1007/s00415-018-09179-8CrossRefPubMed

27.

Olanow CW, Schapira AHV, Roth T (2000) Waking up to sleep episodes in parkinson’s disease. Mov Disord 15(2):212–215. https://doi.org/10.1002/1531-8257(200003)15:2 (〈 212::AID-MDS1002 〉 3.0.CO;2-6)CrossRefPubMed

28.

Monti JM, Jantos H (2008) The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 172:625–646. https://doi.org/10.1016/S0079-6123(08)00929-1CrossRefPubMed

29.

Schenck CH (2019) REM sleep behavior disorder: relevance to epileptologists. Z Epileptol 32(1):6–11CrossRef

30.

American Academy of Sleep Medicine (2014) ICSD-3—international classification of sleep disorders, 3. Aufl. Diagnostic and coding manual. AASM, Darien

31.

Iranzo A, Santamaría J (2005) Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 28(2):203–206. https://doi.org/10.1093/sleep/28.2.203CrossRefPubMed

32.

Gaig C, Iranzo A, Pujol M, Perez H, Santamaria J (2017) Periodic limb movements during sleep mimicking REM sleep behavior disorder: a new form of periodic limb movement disorder. Sleep 40(3):zsw63. https://doi.org/10.1093/sleep/zsw063CrossRef

33.

Haba-Rubio J, Frauscher B, Marques-Vidal P, Toriel J, Tobback N, Andries D, Preisig M, Vollenweider P, Postuma R, Heinzer R (2018) Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep 41(2):zsx197. https://doi.org/10.1093/sleep/zsx197CrossRefPubMed

34.

Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72(15):1296–1300. https://doi.org/10.1212/01.wnl.0000340980.19702.6eCrossRefPubMedPubMedCentral

35.

Stefani A, Högl B (2020) Sleep in parkinson’s disease. Neuropsychopharmacology 45(1):121–128. https://doi.org/10.1038/s41386-019-0448-yCrossRefPubMed

36.

Iranzo A (2018) The REM sleep circuit and how its impairment leads to REM sleep behavior disorder. Cell Tissue Res 373(1):245–266. https://doi.org/10.1007/s00441-018-2852-8CrossRefPubMed

37.

Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, Postuma RB (2021) Prodromal parkinson disease subtypes—key to understanding heterogeneity. Nat Rev Neurol 17(6):349–361. https://doi.org/10.1038/s41582-021-00486-9CrossRefPubMed

38.

Muntean ML, Trenkwalder C, Walters AS, Mollenhauer B, Sixel-Döring F (2015) REM sleep behavioral events and dreaming. J Clin Sleep Med 11(5):537–541. https://doi.org/10.5664/jcsm.4698CrossRefPubMedPubMedCentral

39.

Huang B, Zhang J, Wang J, Chau SWH, Chan JWY, Yu MWM, Li SX, Zhou L, Mok V, Wing YK, Liu Y (2023) Isolated dream-enactment behaviours as a prodromal hallmark of rapid eye movement sleep behaviour disorder. J Sleep Res 32(3):e13791. https://doi.org/10.1111/jsr.13791CrossRefPubMed

40.

Di Fabio N, Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with parkinson’s disease. Eur Neurol 70(5):297–303. https://doi.org/10.1159/000353378CrossRefPubMed

41.

Angelini M, Negrotti A, Marchesi E, Bonavina G, Calzetti S (2011) A study of the prevalence of restless legs syndrome in previously untreated parkinson’s disease patients: absence of co-morbid association. J Neurol Sci 310(1):286–288. https://doi.org/10.1016/j.jns.2011.08.012CrossRefPubMed

42.

Gjerstad MD, Tysnes OB, Larsen JP (2011) Increased risk of leg motor restlessness but not RLS in early parkinson disease. Neurology 77(22):1941–1946. https://doi.org/10.1212/WNL.0b013e31823a0cc8CrossRefPubMed

43.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K, Kanto NMPD investigators (2017) Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson’s disease: a multicenter case-controlled study. Parkinsonism Relat Disord 44:18–22. https://doi.org/10.1016/j.parkreldis.2017.08.007CrossRefPubMed

44.

De Cock VC, Bayard S, Yu H, Grini M, Carlander B, Postuma R, Charif M, Dauvilliers Y (2012) Suggested immobilization test for diagnosis of restless legs syndrome in parkinson’s disease. Mov Disord 27(6):743–749. https://doi.org/10.1002/mds.24969CrossRefPubMed

45.

Marchesi E, Negrotti A, Angelini M, Goldoni M, Abrignani G, Calzetti S (2016) A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with parkinson’s disease during chronic dopaminergic therapy. J Neurol 263(3):441–447. https://doi.org/10.1007/s00415-015-7937-7CrossRefPubMed

46.

Bartl M, Winkelmann J, Högl B, Paulus W, Trenkwalder C (2018) Frequent neurological diseases associated with the restless legs syndrome. Nervenarzt 89(10):1156–1164CrossRefPubMed

47.

Bahia CMCS, Pereira JS, Lopes AJ (2019) Laryngopharyngeal motor dysfunction and obstructive sleep apnea in parkinson’s disease. Sleep Breath 23(2):543–550. https://doi.org/10.1007/s11325-018-1729-0CrossRefPubMed

48.

Crosta F, Desideri G, Marini C (2017) Obstructive sleep apnea syndrome in parkinson’s disease and other parkinsonisms. Funct Neurol 32(3):137–141. https://doi.org/10.11138/FNeur/2017.32.3.137CrossRefPubMedPubMedCentral

49.

Hermann W, Schmitz-Peiffer H, Kasper E, Fauser M, Franke C, Wienecke M, Otto K, Löhle M, Brandt MD, Reichmann H, Storch A (2020) Sleep disturbances and sleep disordered breathing impair cognitive performance in parkinson’s disease. Front Neurosci 14:689. https://doi.org/10.3389/fnins.2020.00689CrossRefPubMedPubMedCentral

50.

Huang JY, Zhang JR, Shen Y, Zhang HJ, Cao YL, Mao CJ, Yang YP, Chen J, Liu CF, Li J (2018) Effect of rapid eye movement sleep behavior disorder on obstructive sleep apnea severity and cognition of parkinson’s disease patients. Chin Med J 131(8):899. https://doi.org/10.4103/0366-6999.229888CrossRefPubMedPubMedCentral

51.

Högl B (2010) Sleep apnea in parkinson’s disease: when is it significant? Sleep Med 11(3):233–235. https://doi.org/10.1016/j.sleep.2009.11.008CrossRefPubMed

52.

Braga-Neto P, da Silva-Júnior FP, Sueli Monte F, de Bruin PF, de Bruin VM (2004) Snoring and excessive daytime sleepiness in parkinson’s disease. J Neurol Sci 217(1):41–45. https://doi.org/10.1016/j.jns.2003.08.010CrossRefPubMed

53.

Kaminska M, O’Sullivan M, Mery VP, Lafontaine AL, Robinson A, Gros P, Martin JG, Benedetti A, Kimoff RJ (2022) Inflammatory markers and BDNF in obstructive sleep apnea (OSA) in parkinson’s disease (PD). Sleep Med 90:258–261. https://doi.org/10.1016/j.sleep.2021.11.018CrossRefPubMed

54.

Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S (2016) Obstructive sleep apnea and cognition in parkinson’s disease. Sleep Med 21:28–34. https://doi.org/10.1016/j.sleep.2016.01.001CrossRefPubMedPubMedCentral

55.

Meng L, Benedetti A, Lafontaine AL, Mery V, Robinson AR, Kimoff J, Gros P, Kaminska M (2020) Obstructive sleep apnea, CPAP therapy and parkinson’s disease motor function: a longitudinal study. Parkinsonism Relat Disord 70:45–50. https://doi.org/10.1016/j.parkreldis.2019.12.001CrossRefPubMed

56.

Cortelli P, Calandra-Buonaura G, Benarroch EE, Giannini G, Iranzo A, Low PA, Martinelli P, Provini F, Quinn N, Tolosa E, Wenning GK, Abbruzzese G, Bower P, Alfonsi E, Ghorayeb I, Ozawa T, Pacchetti C, Pozzi NG, Vicini C, Antonini A, Bhatia KP, Bonavita J, Kaufmann H, Pellecchia MT, Pizzorni N, Schindler A, Tison F, Vignatelli L, Meissner WG (2019) Stridor in multiple system atrophy. Neurology 93(14):630–639. https://doi.org/10.1212/WNL.0000000000008208CrossRefPubMedPubMedCentral

57.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, Seitz C, Simabukuro M, Téllez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaría J, Dalmau J (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88(18):1736–1743. https://doi.org/10.1212/WNL.0000000000003887CrossRefPubMedPubMedCentral

58.

Mantovani S, Smith SS, Gordon R, O’Sullivan JD (2018) An overview of sleep and circadian dysfunction in parkinson’s disease. J Sleep Res 27(3):e12673. https://doi.org/10.1111/jsr.12673CrossRefPubMed

59.

Zhu K, van Hilten JJ, Marinus J (2016) The course of insomnia in parkinson’s disease. Parkinsonism Relat Disord 33:51–57. https://doi.org/10.1016/j.parkreldis.2016.09.010CrossRefPubMed

60.

Seppi K, Chaudhuri RK, Coelho M, Fox SH, Katzenschlager R, Lloret PS, Weintraub D, Sampaio C and the collaborators of the Parkinson’s Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee (2019) Update on treatments for nonmotor symptoms of parkinson’s disease—an evidence-based medicine review. Mov Disord 34(2):180–198. https://doi.org/10.1002/mds.27602CrossRefPubMedPubMedCentral

61.

Taximaimaiti R, Luo X, Wang XP (2021) Pharmacological and non-pharmacological treatments of sleep disorders in parkinson’s disease. Curr Neuropharmacol 19(12):2233–2249. https://doi.org/10.2174/1570159X19666210517115706CrossRefPubMedPubMedCentral

62.

Choi JH, Kim HJ, Lee JY, Yoo D, Im JH, Paek SH, Jeon B (2019) Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson’s disease. PLoS ONE 14(8):e221219. https://doi.org/10.1371/journal.pone.0221219CrossRefPubMedPubMedCentral

Titel: Schlafstörungen bei Parkinson-Krankheit
verfasst von: Kirsi Lange
Jan Simon Gerdes
Berthold Voges
Publikationsdatum: 12.02.2024
Verlag: Springer Medizin
Schlagwörter: Parkinson-Krankheit
Restless-Legs-Syndrom
Obstruktives Schlafapnoesyndrom
Bewegungsstörungen
Schlafbezogene Atmungsstörung
Insomnie
Polysomnografie
Erschienen in: Somnologie / Ausgabe 1/2024
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI: https://doi.org/10.1007/s11818-024-00450-x

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Light therapy glasses during night shift work: a field study

Häusliche Polysomnographie mit Systemen zur Selbstapplikation in der Diagnostik von Schlaferkrankungen

Ein neues Zertifikat der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin : „Psychotherapeutische Schlafmedizin“

Initial validation of the new browser-based application DREEP for diagnosis of common chronic sleep disorders

Luzide Trauminduktion mittels Wake-up-back-to-bed stand-alone im Home-Setting: ein Onlineversuch

Schlafstörungen bei Autoimmunenzephalitiden – praktische Empfehlungen für den klinischen Alltag